Page 139 - medicina-integrativa_compress

CAPÍTULO 12 AUTISMO 129

BIBLIOGRAFÍA umbilical cord blood. Washington, DC, Environmental Working
Group, July 14, 2005.
1. Bertrand J, Mars A, Boyle C, et al: Prevalence autism in a 25. Palmer RF, Blanchard S, Stein Z, et al: Environmental mercury
United States population: The Brick Township, New Jersey, release, special education rates, and autism disorder: An ecological
investigation. Pediatrics 108:1155-1161, 2001. study of Texas Health and Place (in press).
2. Gurney JG, Fritz MS, Ness KK, et al: Analysis of prevalence trends 26. Honda H, Shimizu Y, Rutter M: No effect of MMR withdrawal on
of autism spectrum disorder in Minnesota. Arch Pediatr Adolesc the incidence of autism: A total population study. J Child Psychol
Med 157:622-627, 2003. Psychiatry Allied Disc 46:572-579, 2005.
3. Horvath K, Papadimitriou JC, Rabsztyn A, et al: Gastrointestinal 27. Rimland B, Callaway E, Dreyfus P: The effects of high doses of
abnormalities in children with autistic disorder. J Pediatr 135: vitamin B 6 on autistic children: A double-blind crossover study.
559-563, 1999. Am J Psychiatry 135:472-475, 1978.
4. Torrente F, Ashwood P, Day R, et al: Small intestinal enteropathy 28. Rimland B: High-dose vitamin B 6 and magnesium in treating
with epithelial IgG and complement deposition in children with autism: Response to study by Findling et al. J Autism Dev Disord
regressive autism. Mol Psychiatry 7:375-382, 2002. 28:581-582, 1998.
5. Horvath K, Perman JA: Autistic disorder and gastrointestinal 29. Rimland B: Critique of “Efficacy of vitamin B 6 and magnesium in
disease. Curr Opin Pediatr 14:583-587, 2002. the treatment of autism.” J Autism Dev Disord 28:580-581, 1998.
6. Wakefield AJ, Anthony A, Murch SH, et al: Enterocolitis in children 30. Nye C, Brice A: Combined vitamin B 6 -magnesium treatment
with developmental disorders. Am J Gastroenterol 95:2285-2295, in autism spectrum disorder. Cochrane Database Syst Rev
2000. (4):CD003497, 2002.
7. Rosseneu S, et al: Aerobic gut flora in children with autistic 31. Adams JB, Holloway C: Pilot study of a moderate dose
spectrum disorder and gastrointestinal symptoms. London, Center multivitamin/mineral supplement for children with autistic
for Gastroenterology, Royal Free University. (Publication pending). spectrum disorder. J Altern Complement Med 10:1033-1039,
8. Sandler RH, Finegold SM, Bolte ER, et al: Short-term benefit from 2004.
oral vancomycin treatment of regressive-onset autism [see 32. Dolske MC, Spollen J, McKay S, et al: A preliminary trial of ascorbic
comment]. J Child Neurol 15:429-435, 2000. acid as supplemental therapy for autism. Prog
9. D’Eufemia P, Celli M, Finocchiaro R, et al: Abnormal intestinal Neuropsychopharmacol Biol Psychiatry 17:765-774, 1993.
permeability in children with autism. Acta Paediatr 85:1076-1079, 33. Vancassel S, Durand G, Barthelemy C, et al: Plasma fatty acid
1996. levels in autistic children. Prostaglandins Leukot Essent Fatty Acids
10. Horvath K, Perman JA: Autism and gastrointestinal symptoms. 65:1-7, 2001.
Curr Gastroenterol Rep 4:251-258, 2002. 34. Bryson SE, Rogers SJ, Fombonne E: Autism spectrum disorders:
11. Lucarelli S, Frediani T, Zingoni AM, et al: Food allergy and infantile Early detection, intervention, education, and psychopharmacological
autism. Panminerva Med 37:137-141, 1995. management. Can J Psychiatry 48:506-516, 2003.
12. Jyonouchi H, Sun S, Itokazu N: Innate immunity associated with 35. Knivsberg AM, Reichelt KL, Hoien T, Nodland M: A randomised,
inflammatory responses and cytokine production against common controlled study of dietary intervention in autistic syndromes.
dietary proteins in patients with autism spectrum disorder. Nutr Neurosci 5:251-261, 2002.
Neuropsychobiology 46:76-84, 2002. 36. Lucarelli S, Frediani T, Zingoni AM, et al: Food allergy and infantile
13. Connolly AM, Chez MG, Pestronk A, et al: Serum autoantibodies autism. Panminerva Med 37:137-141, 1995.
to brain in Landau-Kleffner variant, autism, and other neurologic 37. Patrick L, Salik R: The effect of essential fatty acid supplementation
disorders. J Pediatr 134:607-613, 1999. on language development and learning skills in autism and
14. Singh VK, Warren R, Averett R, Ghaziuddin M: Circulating Asperger’s syndrome. Autism-Asperger’s Dig Jan/Feb:36-37, 2005.
autoantibodies to neuronal and glial filament proteins in autism. 38. Richardson AJ, Montgomery P: The Oxford-Durham Study: A
Pediatr Neurol 17:88-90, 1997. randomized, controlled trial of dietary supplementation with fatty
15. Sweeten TL, Bowyer SL, Posey DJ, et al: Increased prevalence of acids in children with developmental coordination disorder.
familial autoimmunity in probands with pervasive developmental Pediatrics 115:1360-1366, 2005
disorders. Pediatrics 112:e420, 2003. 39. Walsh W: Metallothionein promotion therapy in autism spectrum
16. James SJ, Cutler P, Melnyk S, et al: Metabolic biomarkers of disorders. In Rimland B (ed): DAN! (Defeat Autism Now!), Spring
increased oxidative stress and impaired methylation capacity in 2002 Conference Practitioner Training. San Diego, CA, Autism
children with autism. Am J Clin Nutr 80:1611-1617, 2004. Research Institute, 2002.
17. Yorbik O, Sayal A, Akay C, et al: Investigation of antioxidant 40. Chez MG, Buchanan CP, Aimonovitch MC, et al: Double-blind,
enzymes in children with autistic disorder. Prostaglandins Leukot placebo-controlled study of L-carnosine supplementation in
Essent Fatty Acids 67:341-343, 2002. children with autistic spectrum disorders. J Child Neurol 17:
© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.
18. McGinnis WR: Oxidative stress in autism. Altern Ther Health Med 833-837, 2002.
10:22-36, 2004. 41. McCracken JT, McGough J, Shah B, et al: Risperidone in children
19. Ip P, Wong V, Ho M, et al: Mercury exposure in children with with autism and serious behavioral problems. N Engl J Med 347:
autistic spectrum disorder: Case-control study. J Child Neurol 314-321, 2002.
19:431-434, 2004. 42. Research Units on Pediatric Psychopharmacology Autism Network:
20. Holmes AS, Blaxill MF, Haley BE: Reduced levels of mercury in first Risperidone treatment of autistic disorder: Longer-term benefits
baby haircuts of autistic children. Int J Toxicol 22:277-285, 2003. and blinded discontinuation after 6 months. Am J Psychiatry
21. Bradstreet J, Geier DA, Kartzinel JJ, et al: A case-control study of 162:1361-1369, 2005.
mercury burden in children with autistic spectrum disorders. J Am 43. Hollander E, Phillips A, Chaplin W, et al: A placebo-controlled
Phys Surg 8:76-82, 2003. crossover trial of liquid fluoxetine on repetitive behaviors in
22. Geier MR, Geier DA: The potential importance of steroids in the childhood and adolescent autism. Neuropsychopharmacology
treatment of autistic spectrum disorders and other disorders 30:582-589, 2005.
involving mercury toxicity. Med Hypoth 64:946-954, 2005. 44. McDougle CJ, Naylor ST, Cohen DJ, et al: A double-blind, placebo-
23. Geier DA, Geier MR: A two-phased population epidemiological controlled study of fluvoxamine in adults with autistic disorder.
study of the safety of thimerosal-containing vaccines: A follow-up Arch Gen Psychiatry 53:1001-1008, 1996.
analysis. Med Sci Monit 11:CR160-170, 2005. 45. Stigler KA. Desmond LA. Posey DJ, et al: A naturalistic retrospective
24. Body Burden: The Pollution in Newborns. A benchmark analysis of psychostimulants in pervasive developmental disorders.
investigation of industrial chemicals, pollutants, and pesticides in J Child Adolesc Psychopharmacol 14:49-56, 2004.